BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Bio NC

  Premier, Inc. Named A World’s Most Ethical Company® For Ninth Year

  March 7, 2016

   · 

  3 min read
• Drug Development

  Spectrum Pharma Initiates Phase 2 Breast Cancer Trial For Poziotinib, A Novel Pan-HER Inhibitor

  March 7, 2016

   · 

  4 min read
• Business

  Peptidream Announces License Of PDPS Technology To Eli Lilly

  March 7, 2016

   · 

  1 min read
• Drug Development

  Aimmune Announces Phase 2 Follow-On Study Of AR101 For The Treatment Of Peanut Allergy Demonstrated Increased Desensitization And Improved Tolerability With Low-Dose Maintenance

  March 7, 2016

   · 

  10 min read
• Drug Development

  Antibe Therapeutics Receives Approval To Proceed To Phase 2 Clinical Trial

  March 7, 2016

   · 

  2 min read
• Business

  TxCell To Publish 2015 Annual Results And Update Its Strategy And Perspectives On Thursday, March 10, 2016

  March 7, 2016

   · 

  1 min read
• BioMidwest

  Boehringer Ingelheim Release: New Analyses: Adding Spiriva Respimat Effective For Uncontrolled Asthma -- Regardless Of Allergy Subtype

  March 7, 2016

   · 

  8 min read
• Drug Development

  TiGenix Announces Positive 52-Week Phase III Results Of Cx601 In Complex Perianal Fistulas In Crohn’s Disease Patients

  March 7, 2016

   · 

  3 min read
• Pharm Country

  Stentys Successfully Completes €12.6 Million Capital Increase

  March 7, 2016

   · 

  1 min read
• Deals

  Alvogen Announces Acquisition To Expand U.S. Business

  March 7, 2016

   · 

  1 min read